<DOC>
	<DOCNO>NCT02751125</DOCNO>
	<brief_summary>This pilot study aim reconstruct atrophy posterior alveolar mandibular ridge use biomaterial autologous bone marrow derive stem cell ( BMMSC ) insert implant new bone prosthetically guide position .</brief_summary>
	<brief_title>Reconstruction Jaw Bone Using Mesenchymal Stem Cells</brief_title>
	<detailed_description>Eleven patient present need implant retain restoration posterior mandibula alveolar ridge maximum 4.5 mm width . A clinical examination , x- ray Cone Beam CT ( CBCT ) access . A sample patient ` bone marrow extract posterior alveolar ridge , immediately ship collaborate good clinical practice ( GCP ) cell laboratory cell expansion , return 21 day . The stem cell mixed Bi Calcium Phosphate ( BCP ) use augment alveolar ridge . The material cover titanium reinforce membrane closure site . After four six month bone biopsy perform implant instal regenerate bone . The patient follow 1 , 2 , 3 , 5 year implant stability assess . Furthermore new form bone clinically radiologically assessed time .</detailed_description>
	<mesh_term>Atrophy</mesh_term>
	<criteria>Patients present indication implant want implantborne prosthetic restoration . Patients present lateral vertical bone loss ( focus lateral bone loss ) mandible behind canine tooth . Lateral ( width 5 mm less ) bone loss prevent insertion implant without prior bone augmentation . Endentate 6 month region require reconstruction . Endentate concern least 2 miss teeth region require reconstruction . Absence clinical sign infection region require reconstruction . Patients present good dental hygiene ( subjective criterion ) Patients present major oral pathology . Dental crest size le 5 mm . General criterion : Adult patient 18 80 year age . Patients good general health present complete blood count renal hepatic function value within normal limit ( confirm local laboratory test ) . Patients capacity understand medical information give inform consent . ocal criterion : Patients present clinical radiological sign bone infection ( acute chronic osteomyelitis ) . Residual dentition close area require reconstruction untreated endodontic disorder ( apical granuloma apical cyst ) . Untreated oral infection ( cellulitis , periodontitis ) . Patients poor hygiene ( subjective criterion ) . Surgical procedure undertaken area require reconstruction le 6 month prior bone graft . History malignant tumor upper airway / digestive tract jaw . History schedule cervicofacial radiation therapy . General criterion : The patient suffers serious coagulation disorder could require substitution therapy The patient receive VKA therapy , adjust necessary INR exceed 2.5 The patient history allergy iodine local anesthetic ( sulfites , etc . ) . , history hematoma , hemorrhage blood coagulation disorder The patient receive localized iliac crest radiotherapy contraindicate withdrawal irradiate site The patient major skin lesion disease . Patients present bone metabolism disorder : hypophosphatemia , primary parathyroid osteitis secondary chronic renal insufficiency osteomalacia , Paget 's disease , vitamin Drelated disorder , osteoporosis . Pregnant breastfeed woman woman use effective contraception childbearing age . Patients present cancerous disorder ( carcinoma , sarcoma , leukemia , lymphoma ) psychiatric disorder uncontrolled systemic disease ( diabetes , hypertension ) , chronic renal disease . Severe bruxism . History chemotherapy . Smoking alcohol addiction . Occasional consumption alcohol and/or smoke noted case report form . Patients ASA score 0 1 , incapable tolerate general anesthesia . Immunosuppression Body mass index outside normal range , particularly &gt; 30 increase surgical risk time BM harvest iliac crest . Risk remote infection ( orthopedic prosthesis implant previous 6 month , patient present high risk infective endocarditis , presence pulmonary arteriovenous shunt , etc. ) . HIV , HTLV and/or syphilis seropositivity . Hepatitis B C infection . Active autoimmune disease . History immunosuppressant treatment bone marrow treatment . Administration treatment interfere bone metabolism . Patients require antibiotic prophylaxis dental procedure Patients reticent undergo dental care periodontal treatment Concomitant treatment : history treatment current treatment bisphosphonates , long term corticosteroid treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Mesenchymal stem cell</keyword>
	<keyword>bone augmentation</keyword>
	<keyword>bone regeneration</keyword>
</DOC>